Horiba strengthens identity with name change
This article was originally published in Clinica
Horiba ABX, the French company specialising in automated instruments and reagents used in blood analysis, has changed its name to Horiba Medical. The move is to give the firm "a strong unified identity" within its parent company, Japanese conglomerate Horiba Group. Horiba Medical, headquartered in Montpellier, manufactures 25% of all haematology instruments worldwide. It generates around €134.4m ($172m) in revenue and invests over 10% of its turnover in R&D. It was acquired by Horiba Group in 1996, and forms one of the group's five key divisions.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.